* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Interferon Type II & III - Bite
Survey
Document related concepts
Major histocompatibility complex wikipedia , lookup
Lymphopoiesis wikipedia , lookup
Hygiene hypothesis wikipedia , lookup
Molecular mimicry wikipedia , lookup
Immunosuppressive drug wikipedia , lookup
Management of multiple sclerosis wikipedia , lookup
DNA vaccination wikipedia , lookup
Immune system wikipedia , lookup
Polyclonal B cell response wikipedia , lookup
Cancer immunotherapy wikipedia , lookup
Adaptive immune system wikipedia , lookup
Adoptive cell transfer wikipedia , lookup
Psychoneuroimmunology wikipedia , lookup
Transcript
Interferons: Type II & III CATEGORY: RECEPTORS & MOLECULES Interferons: Type II & III Ellen Margaret Moran, Charles Institute of Dermatology, University College Dublin, Ireland Two additional interferon subtypes have also been identified as being biologically significant: type II interferon or IFN-γ and the type III interferons IFN-λ1, IFN-λ2 and IFN-λ3. IFN-γ is secreted by natural killer (NK) cells, T cells and antigen presenting cells (monocytes, macrophages and dendritic cells) whereas to date the only source of type III interferons identified is plasmacytoid dendritic cells (DCs). IFN-γ was initially described as an antiviral factor, however, it has since been demonstrated to contribute to a much wider range of biological activities. Binding of IFN-γ to its receptors promotes cellular immune responses; activation of macrophages and NK cells; upregulation of MHC expression and promoting leucocyte migration. IFN-γ is also considered the key cytokine in the Th1 immune response. Type III interferons are co-expressed with type I interferons by virally infected cells and both contribute to the early antiviral response. In addition, type III IFNs are capable of modulating the adaptive immune response. IFN-λ increases MHC I and II expression on DCs as well as levels of CCR7, the chemokine receptor crucial for DC migration to lymph nodes. The broad functions of the interferon family are evidenced by the treatments currently in use and/or in development that modulate the various members for the treatment of diseases such as chronic hepatitis C infection and multiple sclerosis. . Table 1. Members of the Type II and III Interferon Family Members Cellular Functions source Type II IFN-γ NK cells, - Activates macrophages and NK cells T cells, - Upregulation of MHC expression antigen - Drives leucocyte migration presenting - Mediator of Th1 immune response - Upregulation cells Type III IFN- λ1, IFN-λ2, IFN- Plasmacytoid λ3 DCs of DC MHC I and II expression - Modulation migration of CCR7 mediated DC © The copyright for this work resides with the author Interferons were first described in the late 1950s by two scientists – Isaacs and Lindenmann – who assigned an antiviral factor the name ‘interferon’. This was due to the molecule’s ability to ‘interfere’ with the growth of the influenza virus. In the subsequent twenty years, the type I interferon family – comprising key members such as IFN-α and IFN-β – was well characterised. The type I interferons are considered the first line of defence against numerous viral infections in humans.